Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.

BACKGROUND Intravenous rapacuronium's rapid onset and short duration suggest that intramuscular rapacuronium might facilitate tracheal intubation without prolonged paralysis. Accordingly, the authors injected rapacuronium into the deltoid muscle to determine the optimal dose and time for intubation in pediatric patients. METHODS Unpremedicated patients (aged, 2 months to 3 yr) were studied. Part I: Spontaneous minute ventilation (V(E)) and twitch tension were measured during N2O/halothane anesthesia. Rapacuronium (2.2-5.5 mg/kg, given intramuscularly, n = 23), succinylcholine (4 mg/kg, given intramuscularly, n = 12), or vecuronium (0.1 mg/kg, given intravenously, n = 15) was given. Time to 50% depression of V(E) and 10% recovery of twitch were measured. Dose for each patient was changed 10-20% according to the previous patient's response. Part II: In 22 patients anesthetized with 0.82-1.0% halothane, the optimal rapacuronium dose determined in part I (infants, 2.8 mg/kg; children, 4.8 mg/kg) was given intramuscularly. Laryngoscopy was scored. Time to laryngoscopy was increased or decreased 0.5 min according to the previous patient's response. RESULTS Part I: Rapacuronium typically depressed ventilation in < or = 2 min with 10% twitch recovery in 20-60 min. With succinylcholine, median time to ventilatory depression was 1.3 and 1.1 min for infants and children, respectively; for vecuronium, 0.7 and 0.6 min. Part I: Intubating conditions were good-excellent at 3.0 and 2.5 min in infants and children, respectively; time to 10% twitch recovery (mean +/- SD) was 31 +/- 14 and 36 +/- 14 min in the two groups. CONCLUSIONS This pilot study indicates that deltoid injection of rapacuronium, 2.8 mg/kg in infants and 4.8 mg/kg in children, permits tracheal intubation within 2.5-3.0 min, despite a light plane of anesthesia. Duration of action is intermediate.

[1]  R. Kaplan,et al.  Intramuscular Rocuronium in Infants and Children , 1999 .

[2]  R. Matteo,et al.  Dose-Ranging Study in Younger Adult and Elderly Patients of ORG 9487, a New, Rapid-Onset, Short-Duration Muscle Relaxant , 1997, Anesthesia and analgesia.

[3]  M. Sharma,et al.  Pharmacodynamic Modeling of Vecuronium‐induced Twitch Depression: Rapid Plasma‐Effect Site Equilibration Explains Faster Onset at Resistant Laryngeal Muscles than at the Adductor Pollicis , 1997, Anesthesiology.

[4]  Ronald D. Miller,et al.  Onset and Duration of Rocuronium and Succinylcholine at the Adductor Pollicis and Laryngeal Adductor Muscles in Anesthetized Humans , 1994, Anesthesiology.

[5]  D. Fisher,et al.  Is intramuscular mivacurium an alternative to intramuscular succinylcholine , 1994 .

[6]  M. Jöhr,et al.  Pediatric anesthesia without vascular access: intramuscular administration of atracurium. , 1993, Anesthesia and analgesia.

[7]  R. Khan,et al.  LMA and the stylet: a source of new strength for the old mask. , 1993, Anesthesia and Analgesia.

[8]  M. Zornow,et al.  Tracheal Intubation Without the Use of Muscle Relaxants: A Technique Using Propofol and Varying Doses of Alfentanil , 1992, Anesthesia and analgesia.

[9]  G. Gronert,et al.  Intractable cardiac arrest in children given succinylcholine. , 1992, Anesthesiology.

[10]  K. Omote,et al.  Neuromuscular effects of subcutaneous administration of pancuronium. , 1992, Anesthesiology.

[11]  D. R. Cook,et al.  Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia. , 1992, Anesthesiology.

[12]  C. Meistelman,et al.  Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. , 1991, Anesthesiology.

[13]  C. Meistelman,et al.  Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. , 1990, Anesthesiology.

[14]  C. Meistelman,et al.  Importance of the level of paralysis recovery for a rapid antagonism of vecuronium with neostigmine in children during halothane anesthesia. , 1988, Anesthesiology.

[15]  T. Kirkpatrick,et al.  Plasma morphine concentrations after intramuscular injection into the deltoid or gluteal muscles , 1988, Anaesthesia.

[16]  P. Duvaldestin,et al.  The neuromuscular blocking effect of vecuronium on the human diaphragm. , 1985, Anesthesia and Analgesia.

[17]  L. M. Liu,et al.  Dose response to intramuscular succinylcholine in children. , 1980, Anesthesiology.

[18]  L. Mason,et al.  Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. , 1980, Anesthesiology.

[19]  L. Sheiner,et al.  Pharmacokinetics and Pharmacodynamics of d-Tubocurarine during Nitrous Oxide–Narcotic and Halothane Anesthesia in Man , 1979 .

[20]  C. Blitt,et al.  End-tidal enflurane concentration for endotracheal intubation. , 1977, Anesthesiology.

[21]  C. Blitt,et al.  End-tidal halothane concentration for endotracheal intubation. , 1978, Anesthesiology.

[22]  E. Eger,et al.  The Relationship between Age and Halothane Requirement in Man , 1969, Anesthesiology.

[23]  R. Mazze,et al.  Intralingual Succinylcholine Administration in Children: An Alternative to Intravenous and Intramuscular Routes? , 1968, Anesthesia and analgesia.